Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine versus oxycodone CSCI neurotoxicity trial in terminal patients with renal impairment
NL-OMON44278Phase 4Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in pain comparing Oxycodone CSCI with Morphine CSCI (2 arms). Primary endpoint: Occurrence of delirium between start of CSCI and death. Started Jun 2018; status: active, not recruiting.
02
Drugs
oxycodonemorphine
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON44278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44278.